Plasma met-enkephalin, β-endorphin and leu-enkephalin levels in human hepatic encephalopathy

Eastern Mediterranean Health Journal

Volumn 13, Issue 2, 2007, Pages 257-265

  Kame, Laila ^a   Saleh, A ^a   Morsy, A ^a   Ghali, A ^a   El Khayat, H ^a  

^a THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AMMONIA; BETA ENDORPHIN; BILIRUBIN; LEUCINE ENKEPHALIN; METENKEPHALIN; OPIATE ANTAGONIST;

ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME;

AMMONIA; ANALYSIS OF VARIANCE; BETA-ENDORPHIN; CASE-CONTROL STUDIES; CAUSALITY; EGYPT; ENKEPHALIN, LEUCINE; ENKEPHALIN, METHIONINE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS; METABOLIC CLEARANCE RATE; NALTREXONE; NARCOTIC ANTAGONISTS; NEUROTRANSMITTER AGENTS; RADIOIMMUNOASSAY; RECEPTORS, OPIOID; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 34447280120     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bustamante J et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. Journal of hepatology, 1999, 30:890-5.
2. Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. British medical journal, 1988, 297:1501-4.
3. Thornton JR, Losowsky MS. Methionine enkephalin is increased in plasma in acute liver disease and is present in bile and urine. Journal of hepatology, 1989, 8:53-9.
4. Yurdaydin C et al. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists. Journal of pharmacology and experimental therapeutics, 1995, 273:185-92.
5. De Waele JP et al. Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain. Hepatology, 1996, 24:895-901.
6. Bergasa NV, Jones EA. The pruritis of cholestasis: potential pathogenic and therapeutic implications of opioids. Gastroenterology, 1995, 108:1582-8.
7. Bergasa NV, Dersch CM, Rothman RB. A study of bile acids as opioid receptor ligands in rat brain membranes. Neuroscience letters, 2004, 358(1):68-70.
8. Thornton JR, Dean H, Losowsky MS. Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides? Gut, 1988, 29:1167-72.
9. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology. Oxford, Oxford University Press, 1991.
10. Millan MJ, Herz A. The endocrinology of the opioids. International review of neurobiology, 1985, 26:1-83.
11. Janecka A, Fichna J, Janecki T. Opioid receptors and their ligands. Current topics in medicinal chemistry, 2004, 4(1): 1-17.
12. Basile AS, Jones EA, Skolnick P. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharmacological reviews, 1991, 42:27-71.
13. Butterworth RF. Advances in hepatic encephalopathy and metabolism in liver disease. Newcastle upon Tyne, University of Newcastle, Faculty of Medicine, 1997.
14. Frederickson RC, Norris FH. Enkephalin-induced depression of single neurons in brain areas with opiate receptorsantagonism by naloxone. Science, 1976, 194:440-2.
15. Fry JP, Zieglgangsberger W. Comparison of the effects of GABA and enkephalin on synaptically evoked activity in the rat striatum. Applied neurophysiology, 1979, 42:54-6.
16. Laidlaw J, Read AE, Sherlock S. Morphine tolerance in hepatic cirrhosis. Gastroenterology, 1961,40:389-96.
17. Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annual review of biochemistry, 2004, 73:53-90.
18. Ozsoylu S, Kocak N. Naloxone in hepatic encephalopathy. American journal of diseases of children, 1985,139:749-50.
19. Eguchi M. Recent advances in selective opioid receptor agonists and antagonists. Medical care research and review, 2004, 24(2): 182-212.
20. Ferenci P et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 2002, 35(3):716-21.
21. Mondzac A, Ehrlich GE, Seegmiller JE. An enzymatic determination of ammonia in biological fluids. Journal of laboratory and clinical medicine, 1965, 66(3):526-31.
22. Swain MG et al. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology, 1992, 103:630-5.
23. Ong JP et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. American journal of medicine, 2003, 114(3): 188-93.
24. Kramer Let al. Comparison of ammonia partial pressure and total ammonia in hepatic encephalopathy. Hepatology, 2000, 31:30-4.
25. Nicolao F et al. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. Journal of hepatology, 2003, 38(4):441-6.
26. Yurdaydin C et al. Opioid receptor ligands in human hepatic, encephalopathy. Journal of hepatology, 1998, 29:796-801.
27. Viveros OH et al. Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines. Molecular pharmacology, 1979, 16:1101-8.
28. Polak JM et al. Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet, 1977, 1(8019):972-4.
29. Schultzberg M et al. Enkephalin-like immunoreactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary glands. Acta physiologica Scandinavica, 1978, 103:475-7.
30. Bergasa NV et al. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. American journal of physiology, 1995, 268:346-54.